ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

3 links0 made here, not in the record5 judgments2 judges (the rules as one: Rule based)0 record changes seen
Claude Opus 5.5Rule based
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT07376382A Phase Ⅲ Clinical Study ofSYS6010 in Combination WithOsimertinib in PatientsWith Locally Advanced orMetastatic NSCLCCSPC Megalith BiopharmaceuticaPhase 3 · not yet recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSNSCLCNo longer in the registry's filing›Nov 14 · Rule based · Not readNot readDRUGSAnti-EGFR Antibody-drug Con…Entry “SYS6010”, read by our name rule›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedOsimertinibIntervention entry›Nov 3 · Claude Opus 5.5 · Background · partnerNov 18 · Rule based · BackgroundBackground · partner

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Anti-EGFR Antibody-drug Conjugate CPO301

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “SYS6010”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 3Anti-EGFR Antibody-drug Conjugate CPO301Claude Opus 5.5TestedCurrent
Nov 3OsimertinibClaude Opus 5.5Background · partnerCurrent
Nov 14NSCLCRule based · condition-kind ruleNot readCurrent
Nov 18Anti-EGFR Antibody-drug Conjugate CPO301Rule based · role ruleTestedAgrees
Nov 18OsimertinibRule based · role ruleBackgroundAgrees

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.